| Dr Nonna V Kolomeyevskaya, MD | |
|
736 Cambridge St, Brighton, MA 02135-2907 | |
| (617) 562-7406 | |
| Not Available |
| Full Name | Dr Nonna V Kolomeyevskaya |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 736 Cambridge St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962708644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 289541 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth's Medical Center | Brighton, MA | Hospital |
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Morton Hospital | Taunton, MA | Hospital |
| Holy Family Hospital | Methuen, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
In a study prompted in part by suggestions from people with mental illness, Johns Hopkins researchers found that a history of Candida yeast infections was more common in a group of men with schizophrenia or bipolar disorder than in those without these disorders, and that women with schizophrenia or bipolar disorder who tested positive for Candida performed worse on a standard memory test than women with schizophrenia or bipolar disorder who had no evidence of past infection.
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
With Congress due back to work in Washington, D.C., after its spring recess, the next stage of the budget battle is expected to heat up. News reports detail the part Medicare and Medicaid will play in the debate.
› Verified 3 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
In a study prompted in part by suggestions from people with mental illness, Johns Hopkins researchers found that a history of Candida yeast infections was more common in a group of men with schizophrenia or bipolar disorder than in those without these disorders, and that women with schizophrenia or bipolar disorder who tested positive for Candida performed worse on a standard memory test than women with schizophrenia or bipolar disorder who had no evidence of past infection.
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
With Congress due back to work in Washington, D.C., after its spring recess, the next stage of the budget battle is expected to heat up. News reports detail the part Medicare and Medicaid will play in the debate.
› Verified 3 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
In a study prompted in part by suggestions from people with mental illness, Johns Hopkins researchers found that a history of Candida yeast infections was more common in a group of men with schizophrenia or bipolar disorder than in those without these disorders, and that women with schizophrenia or bipolar disorder who tested positive for Candida performed worse on a standard memory test than women with schizophrenia or bipolar disorder who had no evidence of past infection.
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
With Congress due back to work in Washington, D.C., after its spring recess, the next stage of the budget battle is expected to heat up. News reports detail the part Medicare and Medicaid will play in the debate.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nonna V Kolomeyevskaya, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 562-7406 | Dr Nonna V Kolomeyevskaya, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 562-7406 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
In a study prompted in part by suggestions from people with mental illness, Johns Hopkins researchers found that a history of Candida yeast infections was more common in a group of men with schizophrenia or bipolar disorder than in those without these disorders, and that women with schizophrenia or bipolar disorder who tested positive for Candida performed worse on a standard memory test than women with schizophrenia or bipolar disorder who had no evidence of past infection.
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
With Congress due back to work in Washington, D.C., after its spring recess, the next stage of the budget battle is expected to heat up. News reports detail the part Medicare and Medicaid will play in the debate.
› Verified 3 days ago
Joelle M Lieman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 11 Nevins St, Mob Suite 406, Brighton, MA 02135 Phone: 617-562-7006 Fax: 617-562-7966 | |
Michael A Steller, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-562-7406 Fax: 617-562-7021 | |
Lucy A Bayer-zwirello, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Smc 7th Floor, Brighton, MA 02135 Phone: 617-562-7026 Fax: 617-779-6783 | |
Karen Jean Poley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11 Nevins St., Ste 407, Brighton, MA 02135 Phone: 617-783-0095 Fax: 617-783-4460 | |
Dr. Diana Rodriguez, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-584-8735 | |
Katherine Marshall, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11 Nevins St, Suite 406, Brighton, MA 02135 Phone: 617-562-7948 Fax: 617-562-7966 | |
Dr. Karen E Franklin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge Street, Smc 7, Brighton, MA 02135 Phone: 617-562-7026 |